AstraZeneca Reports Phase III Trial of Anselamimab Did Not Meet Primary Goal
AstraZeneca announces Phase III trial of anselamimab failed to meet primary endpoint, impacting pipeline outlook. #AstraZeneca #ClinicalTrialUpdate
Insights Team
Ford Announces $570 Million Field Service Action for Certain Vehicles
Ford initiates $570M field service action addressing safety and quality issues in select vehicle models. #Ford #FieldServiceAction
News Corp Provides Update on Stock Repurchase Program in SEC Filing
News Corp updates shareholders on its ongoing stock repurchase program, reflecting confidence in financial strength and shareholder value. #NewsCorp #StockRepurchase
NutriBand Authorizes New Series A Preferred Stock and Announces Dividend
NutriBand authorizes new Series A preferred stock issuance and declares dividend, signaling growth and shareholder value focus. #NutriBand #PreferredStock
reAlpha Tech Corp. Enters Waiver Agreement with Streeterville Capital
reAlpha Tech Corp. secures waiver agreement with Streeterville Capital, enhancing financial flexibility amid growth initiatives. #reAlphaTech #WaiverAgreement
Dermata Therapeutics Shareholders Approve Reverse Stock Split and Key Proposals
Dermata Therapeutics shareholders approve reverse stock split and critical proposals to strengthen capital structure and support growth. #DermataTherapeutics #ReverseStockSplit
Universal Electronics Appoints Richard K. Carnifax as Interim CEO
Universal Electronics names Richard K. Carnifax as interim CEO, aiming to strengthen leadership during transition. #UniversalElectronics #LeadershipUpdate
Enhanced Performance by 87%, 70% Less Data: Tianjin University’s Chemical Toxicity Prediction Model Published in Nature Sub-Journal}
Tianjin University and collaborators developed a novel chemical toxicity prediction model, achieving 87% performance improvement and reducing data requirements by 70%, published in Nature Communications.
Seed Round Valuation Reaches $12 Billion: Can She Build Another OpenAI?}
Thinking Machines Lab, founded by former OpenAI CTO Mira Murati, raised $2 billion in seed funding, valuing it at $12 billion, sparking speculation about creating a new AI giant.
Vienna ACL 2025: Join the Machine Intelligence Heart Talent Dinner, Free Meetup!}
Join the ACL 2025 in Vienna for the Machine Intelligence Heart Talent Meetup—an informal event to connect, discuss cutting-edge AI topics, and network with peers. Free registration!